LOADING
Comparing AbbVie Inc (ABBV) and Cisco Systems (CSCO) across the Health Care and Technology sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | ABBV | CSCO |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $443.4B | $431.4B |
| P/E Ratio | 70.5 | 32.9 |
| Forward P/E | 15.4 | 20.3 |
| PEG Ratio | 0.35 | 1.01 |
| EPS | $3.56 | $3.33 |
| Revenue Growth (YoY) | 10.2% | 17.6% |
| Profit Margin | 9.8% | 20.9% |
| Return on Equity | 62.3% | 27.3% |
| Dividend Yield | 2.75% | 1.52% |
| Beta | 0.28 | 0.99 |
| 52-Week High | $267.47 | $129.88 |
| 52-Week Low | $189.40 | $64.79 |
| Volume | -- | -- |
AbbVie Inc is the larger company by market capitalization. Cisco Systems trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. AbbVie Inc offers a higher dividend yield for income investors. Cisco Systems has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.